Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28589386 | 0.79 | FFAR3 (0.36) | FFAR3 | |
| SCHEMBL15114534 | 0.78 | FFAR3 (0.34) | FFAR3 | |
| SCHEMBL1669030 | 0.74 | — | — | |
| SCHEMBL1626773 | 0.71 | — | — | |
| SCHEMBL11246632 | 0.71 | — | — | |
| SCHEMBL1265631 | 0.71 | — | — | |
| SCHEMBL15571664 | 0.69 | — | — | |
| SCHEMBL27958049 | 0.69 | FFAR3 (0.36) | FFAR3 | |
| SCHEMBL15116676 | 0.67 | GLS (0.31) | — | |
| SCHEMBL887928 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2195308-A2 | ANTIINFECTIVE FLAVONONOL COMPOUNDS AND METHODS OF USE THEREOF | Herbalscience Group LLC (US) | 2010-06-16 | — | — | EP | disclosed |
| US-20090092624-A1 | Antiinfective Flavononol Compounds and Methods of Use Thereof | HERBALSCIENCE GROUP, LLC | 2009-04-09 | — | — | US | disclosed |
| WO-2009026176-A2 | ANTIINFECTIVE FLAVONONOL COMPOUNDS AND METHODS OF USE THEREOF | HERBALSCIENCE GROUP LLC (US) | 2009-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090092624-A1 | Antiinfective Flavononol Compounds and Methods of Use Thereof | MPO, VIP, FABP2 | FFAR3 3954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.